Report Detail
Global Allergic Asthma Therapeutics Market Insights, Forecast to 2025
- RnM2997262 |
- 05 March, 2019 |
- Global |
- 129 Pages |
- QYResearch |
- Pharma & Healthcare
The global Allergic Asthma Therapeutics market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Allergic Asthma Therapeutics market based on company, product type, end user and key regions.
This report studies the global market size of Allergic Asthma Therapeutics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Allergic Asthma Therapeutics in these regions.
This research report categorizes the global Allergic Asthma Therapeutics market by top players/brands, region, type and end user. This report also studies the global Allergic Asthma Therapeutics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Aslan Pharmaceuticals Pte. Ltd.
Axikin Pharmaceuticals, Inc.
Baxalta Incorporated
Chiesi Farmaceutici SpA
Circassia Pharmaceuticals Plc
CSL Limited
Fountain Biopharma Inc.
GlaxoSmithKline Plc
Hydra Biosciences, Inc.
Infinity Pharmaceuticals, Inc.
Kineta, Inc.
Mabtech Limited
Marinomed Biotechnologie GmbH
Mycenax Biotech Inc.
NeoPharm Co., Ltd.
Oxagen Limited
Panacea Biotec Limited
Market size by Product
ASM-8
AXP-1275
Beta-escin
CHF-6001
CSL-311
Dalazatide
Others
Market size by End User
Clinic
Research Center
Hospital
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Allergic Asthma Therapeutics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Allergic Asthma Therapeutics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Allergic Asthma Therapeutics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Allergic Asthma Therapeutics submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Allergic Asthma Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Allergic Asthma Therapeutics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Allergic Asthma Therapeutics Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Allergic Asthma Therapeutics Market Size Growth Rate by Product
- 1.4.2 ASM-8
- 1.4.3 AXP-1275
- 1.4.4 Beta-escin
- 1.4.5 CHF-6001
- 1.4.6 CSL-311
- 1.4.7 Dalazatide
- 1.4.8 Others
- 1.5 Market by End User
- 1.5.1 Global Allergic Asthma Therapeutics Market Size Growth Rate by End User
- 1.5.2 Clinic
- 1.5.3 Research Center
- 1.5.4 Hospital
- 1.5.5 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Allergic Asthma Therapeutics Market Size
- 2.1.1 Global Allergic Asthma Therapeutics Revenue 2014-2025
- 2.1.2 Global Allergic Asthma Therapeutics Sales 2014-2025
- 2.2 Allergic Asthma Therapeutics Growth Rate by Regions
- 2.2.1 Global Allergic Asthma Therapeutics Sales by Regions
- 2.2.2 Global Allergic Asthma Therapeutics Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Allergic Asthma Therapeutics Sales by Manufacturers
- 3.1.1 Allergic Asthma Therapeutics Sales by Manufacturers
- 3.1.2 Allergic Asthma Therapeutics Sales Market Share by Manufacturers
- 3.1.3 Global Allergic Asthma Therapeutics Market Concentration Ratio (CR5 and HHI)
- 3.2 Allergic Asthma Therapeutics Revenue by Manufacturers
- 3.2.1 Allergic Asthma Therapeutics Revenue by Manufacturers (2014-2019)
- 3.2.2 Allergic Asthma Therapeutics Revenue Share by Manufacturers (2014-2019)
- 3.3 Allergic Asthma Therapeutics Price by Manufacturers
- 3.4 Allergic Asthma Therapeutics Manufacturing Base Distribution, Product Types
- 3.4.1 Allergic Asthma Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Allergic Asthma Therapeutics Product Type
- 3.4.3 Date of International Manufacturers Enter into Allergic Asthma Therapeutics Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Allergic Asthma Therapeutics Sales by Product
- 4.2 Global Allergic Asthma Therapeutics Revenue by Product
- 4.3 Allergic Asthma Therapeutics Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Allergic Asthma Therapeutics Breakdown Data by End User
6 North America
- 6.1 North America Allergic Asthma Therapeutics by Countries
- 6.1.1 North America Allergic Asthma Therapeutics Sales by Countries
- 6.1.2 North America Allergic Asthma Therapeutics Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Allergic Asthma Therapeutics by Product
- 6.3 North America Allergic Asthma Therapeutics by End User
7 Europe
- 7.1 Europe Allergic Asthma Therapeutics by Countries
- 7.1.1 Europe Allergic Asthma Therapeutics Sales by Countries
- 7.1.2 Europe Allergic Asthma Therapeutics Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Allergic Asthma Therapeutics by Product
- 7.3 Europe Allergic Asthma Therapeutics by End User
8 Asia Pacific
- 8.1 Asia Pacific Allergic Asthma Therapeutics by Countries
- 8.1.1 Asia Pacific Allergic Asthma Therapeutics Sales by Countries
- 8.1.2 Asia Pacific Allergic Asthma Therapeutics Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Allergic Asthma Therapeutics by Product
- 8.3 Asia Pacific Allergic Asthma Therapeutics by End User
9 Central & South America
- 9.1 Central & South America Allergic Asthma Therapeutics by Countries
- 9.1.1 Central & South America Allergic Asthma Therapeutics Sales by Countries
- 9.1.2 Central & South America Allergic Asthma Therapeutics Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Allergic Asthma Therapeutics by Product
- 9.3 Central & South America Allergic Asthma Therapeutics by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Allergic Asthma Therapeutics by Countries
- 10.1.1 Middle East and Africa Allergic Asthma Therapeutics Sales by Countries
- 10.1.2 Middle East and Africa Allergic Asthma Therapeutics Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Allergic Asthma Therapeutics by Product
- 10.3 Middle East and Africa Allergic Asthma Therapeutics by End User
11 Company Profiles
- 11.1 Aslan Pharmaceuticals Pte. Ltd.
- 11.1.1 Aslan Pharmaceuticals Pte. Ltd. Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Aslan Pharmaceuticals Pte. Ltd. Allergic Asthma Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Aslan Pharmaceuticals Pte. Ltd. Allergic Asthma Therapeutics Products Offered
- 11.1.5 Aslan Pharmaceuticals Pte. Ltd. Recent Development
- 11.2 Axikin Pharmaceuticals, Inc.
- 11.2.1 Axikin Pharmaceuticals, Inc. Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Axikin Pharmaceuticals, Inc. Allergic Asthma Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Axikin Pharmaceuticals, Inc. Allergic Asthma Therapeutics Products Offered
- 11.2.5 Axikin Pharmaceuticals, Inc. Recent Development
- 11.3 Baxalta Incorporated
- 11.3.1 Baxalta Incorporated Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Baxalta Incorporated Allergic Asthma Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Baxalta Incorporated Allergic Asthma Therapeutics Products Offered
- 11.3.5 Baxalta Incorporated Recent Development
- 11.4 Chiesi Farmaceutici SpA
- 11.4.1 Chiesi Farmaceutici SpA Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Chiesi Farmaceutici SpA Allergic Asthma Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Chiesi Farmaceutici SpA Allergic Asthma Therapeutics Products Offered
- 11.4.5 Chiesi Farmaceutici SpA Recent Development
- 11.5 Circassia Pharmaceuticals Plc
- 11.5.1 Circassia Pharmaceuticals Plc Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Circassia Pharmaceuticals Plc Allergic Asthma Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Circassia Pharmaceuticals Plc Allergic Asthma Therapeutics Products Offered
- 11.5.5 Circassia Pharmaceuticals Plc Recent Development
- 11.6 CSL Limited
- 11.6.1 CSL Limited Company Details
- 11.6.2 Company Business Overview
- 11.6.3 CSL Limited Allergic Asthma Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 CSL Limited Allergic Asthma Therapeutics Products Offered
- 11.6.5 CSL Limited Recent Development
- 11.7 Fountain Biopharma Inc.
- 11.7.1 Fountain Biopharma Inc. Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Fountain Biopharma Inc. Allergic Asthma Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Fountain Biopharma Inc. Allergic Asthma Therapeutics Products Offered
- 11.7.5 Fountain Biopharma Inc. Recent Development
- 11.8 GlaxoSmithKline Plc
- 11.8.1 GlaxoSmithKline Plc Company Details
- 11.8.2 Company Business Overview
- 11.8.3 GlaxoSmithKline Plc Allergic Asthma Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 GlaxoSmithKline Plc Allergic Asthma Therapeutics Products Offered
- 11.8.5 GlaxoSmithKline Plc Recent Development
- 11.9 Hydra Biosciences, Inc.
- 11.9.1 Hydra Biosciences, Inc. Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Hydra Biosciences, Inc. Allergic Asthma Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Hydra Biosciences, Inc. Allergic Asthma Therapeutics Products Offered
- 11.9.5 Hydra Biosciences, Inc. Recent Development
- 11.10 Infinity Pharmaceuticals, Inc.
- 11.10.1 Infinity Pharmaceuticals, Inc. Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Infinity Pharmaceuticals, Inc. Allergic Asthma Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Infinity Pharmaceuticals, Inc. Allergic Asthma Therapeutics Products Offered
- 11.10.5 Infinity Pharmaceuticals, Inc. Recent Development
- 11.11 Kineta, Inc.
- 11.12 Mabtech Limited
- 11.13 Marinomed Biotechnologie GmbH
- 11.14 Mycenax Biotech Inc.
- 11.15 NeoPharm Co., Ltd.
- 11.16 Oxagen Limited
- 11.17 Panacea Biotec Limited
12 Future Forecast
- 12.1 Allergic Asthma Therapeutics Market Forecast by Regions
- 12.1.1 Global Allergic Asthma Therapeutics Sales Forecast by Regions 2019-2025
- 12.1.2 Global Allergic Asthma Therapeutics Revenue Forecast by Regions 2019-2025
- 12.2 Allergic Asthma Therapeutics Market Forecast by Product
- 12.2.1 Global Allergic Asthma Therapeutics Sales Forecast by Product 2019-2025
- 12.2.2 Global Allergic Asthma Therapeutics Revenue Forecast by Product 2019-2025
- 12.3 Allergic Asthma Therapeutics Market Forecast by End User
- 12.4 North America Allergic Asthma Therapeutics Forecast
- 12.5 Europe Allergic Asthma Therapeutics Forecast
- 12.6 Asia Pacific Allergic Asthma Therapeutics Forecast
- 12.7 Central & South America Allergic Asthma Therapeutics Forecast
- 12.8 Middle East and Africa Allergic Asthma Therapeutics Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Allergic Asthma Therapeutics Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Allergic Asthma Therapeutics . Industry analysis & Market Report on Allergic Asthma Therapeutics is a syndicated market report, published as Global Allergic Asthma Therapeutics Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Allergic Asthma Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
